Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.79% |
| 2 | Healthcare | 13.71% |
| 3 | Financials | 10.83% |
| 4 | Industrials | 9.88% |
| 5 | Consumer Staples | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Etsy
ETSY
$7.4B
| $1.64M | ﹤0.01% |
+198,600
| New | +$2.02M |
|
2227
RELX
RELX
$60.4B
| $1.64M | ﹤0.01% |
91,900
+6,400
| +7% | +$114K |
|
2228
Fresenius Medical Care
FMS
$12.6B
| $1.64M | ﹤0.01% |
+39,150
| New | +$1.65M |
|
|
CDMO
2229
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $1.63M | ﹤0.01% |
199,246
+165,367
| +488% | +$1.34M |
|
|
QUMU
2230
DELISTED
Qumu Corp.
QUMU
| $1.63M | ﹤0.01% |
600,759
+12,629
| +2% | +$41.4K |
|
|
AVHI
2231
DELISTED
A V Homes, Inc.
AVHI
| $1.63M | ﹤0.01% |
127,100
-6,899
| -5% | -$91.7K |
|
|
BBQ
2232
DELISTED
BBQ Holdings, Inc. Common Stock
BBQ
| $1.63M | ﹤0.01% |
234,120
+45,020
| +24% | +$426K |
|
2233
Acco Brands
ACCO
$399M
| $1.62M | ﹤0.01% |
+227,730
| New | +$1.77M |
|
|
FGH
2234
DELISTED
FG Group Holdings Inc.
FGH
| $1.62M | ﹤0.01% |
352,300
-26,300
| -7% | -$119K |
|
|
CEB
2235
DELISTED
CEB Inc.
CEB
| $1.62M | ﹤0.01% |
26,393
-130,607
| -83% | -$9.26M |
|
2236
Acadia Realty Trust
AKR
$2.84B
| $1.61M | ﹤0.01% |
48,700
+1,400
| +3% | +$45.7K |
|
|
AMCC
2237
DELISTED
Applied Micro Circuits Corporation New
AMCC
| $1.61M | ﹤0.01% |
+253,136
| New | +$1.71M |
|
|
GDEN
2238
DELISTED
Golden Entertainment
GDEN
| $1.61M | ﹤0.01% |
157,200
+38,700
| +33% | +$378K |
|
2239
Hurco Companies Inc
HURC
$144M
| $1.6M | ﹤0.01% |
60,401
+13,219
| +28% | +$352K |
|
|
PSTB
2240
DELISTED
Park Sterling Corp.
PSTB
| $1.6M | ﹤0.01% |
218,723
+36,672
| +20% | +$270K |
|
2241
TechTarget
TTGT
$265M
| $1.6M | ﹤0.01% |
198,900
-21,700
| -10% | -$188K |
|
|
KW
2242
DELISTED
Kennedy-Wilson Holdings
KW
| $1.59M | ﹤0.01% |
66,200
-3,200
| -5% | -$78.7K |
|
2243
Timken Company
TKR
$9.03B
| $1.59M | ﹤0.01% |
55,700
+31,100
| +126% | +$936K |
|
|
TLRA
2244
DELISTED
Telaria, Inc.
TLRA
| $1.59M | ﹤0.01% |
772,189
+127,489
| +20% | +$250K |
|
|
EVRI
2245
DELISTED
Everi Holdings
EVRI
| $1.59M | ﹤0.01% |
362,078
-29,522
| -8% | -$126K |
|
2246
Kennametal
KMT
$2.35B
| $1.59M | ﹤0.01% |
82,800
-207,329
| -71% | -$5.35M |
|
|
PRTK
2247
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $1.59M | ﹤0.01% |
83,813
-15,000
| -15% | -$286K |
|
2248
Watts Water Technologies
WTS
$12.9B
| $1.59M | ﹤0.01% |
31,973
-21,927
| -41% | -$1.2M |
|
2249
Arbutus Biopharma
ABUS
$908M
| $1.58M | ﹤0.01% |
356,000
+245,900
| +223% | +$1.35M |
|
2250
Synopsys
SNPS
$78.8B
| $1.58M | ﹤0.01% |
+34,634
| New | +$1.67M |
|
Similar funds
Jim Simons's Q4 2015 Portfolio in Review
As of Q4 2015, Jim Simons held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Jim Simons deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Jim Simons's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Jim Simons added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Jim Simons's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Jim Simons fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Jim Simons's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Jim Simons opened 509 new positions and closed 386 in Q4 2015.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.